ARYA Sciences Acquisition Corp IV
NASDAQ Capital MarketTotal Valuation
ARYA Sciences Acquisition Corp IV carries a market capitalization of 50.04M, placing it among publicly traded companies globally.
| Market Cap | 50.04M |
| Enterprise Value | N/A |
Share Statistics
ARYA Sciences Acquisition Corp IV currently has 7.54M shares outstanding.
| Shares Outstanding | 7.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | -82.56 |
| P/OCF Ratio | -82.56 |
Financial Position
ARYA Sciences Acquisition Corp IV maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -10.17 |
| Return on Assets (ROA) | -6.73 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
ARYA Sciences Acquisition Corp IV's stock has declined approximately -38.0597% over the past 52 weeks. The 50-day moving average sits at 10.32, while the 200-day moving average is 10.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | -38.0597% |
| 50-Day Moving Average | 10.32 |
| 200-Day Moving Average | 10.92 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -4.40M, while operating income came in at -4.40M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -4.40M |
| Pretax Income | -2.54M |
| Net Income | -2.54M |
| EBITDA | -4.40M |
| EBIT | -4.40M |
| Earnings Per Share (EPS) | -0.34 |
Balance Sheet
Total book value stands at 21.98M, with working capital of -12.00M providing operational flexibility.
| Cash & Cash Equivalents | 87,505.00 |
| Total Debt | N/A |
| Net Debt | 3.06M |
| Equity (Book Value) | 21.98M |
| Book Value Per Share | 2.91 |
| Working Capital | -12.00M |
Cash Flow
ARYA Sciences Acquisition Corp IV produced -1.03M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.03M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.03M |
| FCF Per Share | -0.14 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.28 |
| FCF Yield | -1.21 |
Scores
ARYA Sciences Acquisition Corp IV posts an Altman Z-Score of 2.10, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.10 |